NDC 54868-4535-2 - LEVOXYL
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54868-4535
- Requested NDC
- 54868-4535-2
- Package NDCs from labels
- 54868-4535-1, 54868-4535-2
- Manufacturer
- Physicians Total Care, Inc.
- Effective date
- 2013-08-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levoxyl ® (levothyroxine sodium tablets, USP) | Physicians Total Care, Inc. | 2013-08-19 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 54868-4535-1 | 2019-09-24 | C162847 | 48780-1 | 9350213a-44f6-c013-e053-90daa90a1393 | Levoxyl ® (levothyroxine sodium tablets, USP) |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54868-4535-1 | LEVOXYL | 30 in 1 BOTTLE | TABLET | 30 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 54868-4535 | LEVOXYL (LEVOTHYROXINE SODIUM) TABLET [PHYSICIANS TOTAL CARE, INC.] | 5 | 1 package rows | 20130820_951c6e16-7251-42ed-ac19-d8367a6aee4f.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 54868-4535-0 | EA - Each | 54868-4535 | b4aef346-caf3-4da3-8d9d-1925e154fab5 | 1 | 2012-07-24 |
| 54868-4535-1 | EA - Each | 54868-4535 | e84f8d98-5131-4014-927f-495343aa1e72 | 1 | 2012-07-24 |
| 54868-4535-2 | EA - Each | 54868-4535 | 2dc70794-405b-4bee-8a56-d732a9fcb6e0 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium Bicarbonate | SODIUM BICARBONATE | Steriscience Specialties Private Limited | eb2996b4-c04c-4678-b8a9-5cbbe509bb70 | 2024-03-04 | Warnings, Adverse reactions | 8MDF5V39QO |
| LEVOTHYROXINE SODIUM | LEVOTHYROXINE SODIUM | Macleods Pharmaceuticals Limited | b8c20f76-3ee6-4b29-b77f-ed4ad1baaed9 | 2024-03-04 | Boxed warning, Warnings, Adverse reactions | 966248 892251 966222 966270 892246 966221 966224 966249 966220 966225 966253 9J765S329G |
| Sodium Bicarbonate | SODIUM BICARBONATE | Bryant Ranch Prepack | 4493d7c5-f2c3-416e-a5c1-35398fc7f61d | 2024-02-29 | Boxed warning, Warnings | 8MDF5V39QO |
| SODIUM BICARBONATE | SODIUM BICARBONATE | HF Acquisition Co LLC, DBA HealthFirst | a5eedf57-2783-b3d0-e053-2a95a90a9ff5 | 2024-02-22 | Warnings, Adverse reactions | 8MDF5V39QO |
| Synthroid | LEVOTHYROXINE SODIUM | AbbVie Inc. | 1e11ad30-1041-4520-10b0-8f9d30d30fcc | 2024-02-20 | Boxed warning, Warnings, Adverse reactions | 966248 892251 966222 966270 892246 966221 966224 966249 966220 966225 966253 9J765S329G |
| SODIUM BICARBONATE | SODIUM BICARBONATE | HF Acquisition Co LLC, DBA HealthFirst | 76131655-3a87-feac-e053-2991aa0a82a1 | 2024-01-28 | Warnings, Adverse reactions | 8MDF5V39QO |
| N03 EXCHEM | ALLIUM SATIVUM, ARSENICUM ALBUM, BENZOICUM ACIDUM, BERBERIS VULGARIS, BETULA VERRUCOSA, CALCAREA CARBONICA, CARBOLICUM ACIDUM, CHELIDONIUM MAJUS, CHLORINUM, CITRICUM ACIDUM, HISTAMINUM, ICHTHYOLUM, JUNIPERUS COMMUNIS, LYCOPODIUM CLAVATUM, MERCURIUS SOLUBILIS, NATRUM BICARBONICUM, SODIUM HYPOCHLORITE, SOLIDAGO VIRGAUREA, SULPHUR | Apex Energetics Inc. | ba73a050-9a5d-1549-e053-2a95a90a62aa | 2024-01-08 | Warnings | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Pharma Nobis, LLC | e42f674b-1a70-6a3c-e053-2995a90afa72 | 2023-12-22 | Warnings | 8MDF5V39QO |
| HEB Extra Strength Effervescent Antacid and Pain Relief | ASPIRIN, CITRIC ACID, SODIUM BICARBONATE | H. E. Butt Grocery Company | 9e502bd0-8042-8674-e053-2995a90a3d15 | 2023-12-18 | Warnings | 8MDF5V39QO |
| Medis Sodium Bicarbonate | SODIUM BICARBONATE | Humco Holding Group, Inc | 5da32469-58fc-14b1-e053-2a91aa0a74c4 | 2023-12-15 | Warnings | 8MDF5V39QO |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 804d64c9-9804-4d6d-adb2-5036c0be8b5c | 2023-12-12 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| Levothyroxine Sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 3e77de84-6f59-40ac-a1a4-7bfe30387823 | 2023-12-12 | Boxed warning, Warnings, Adverse reactions | 966225 9J765S329G |
| Sodium Bicarbonate Antacid | SODIUM BICARBONATE | Rugby Laboratories | e73b5871-4a87-4473-ab00-5e5395be017d | 2023-12-06 | Warnings | 8MDF5V39QO |
| INON | ALUMINUM HYDROXIDE, MAGNESIUM CARBONATE, SODIUM BICARBONATE | Sato Pharmaceutical Co., Ltd. | e86d9c57-c877-49f1-a405-95a9a226ccf3 | 2023-12-04 | Warnings | 8MDF5V39QO |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | Proficient Rx LP | 89df6a0f-6602-4c22-a052-b565ea8368a7 | 2023-12-01 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 60a0bc29-4283-4ae9-9173-5caf9266f723 | 2023-11-16 | Boxed warning, Warnings, Adverse reactions | 966221 9J765S329G |
| Sodium Bicarbonate | SODIUM BICARBONATE | A-S Medication Solutions | d89406d3-4356-4a8c-acc1-89efe1d27010 | 2023-11-14 | Warnings, Adverse reactions | 8MDF5V39QO |
| Sodium Bicarbonate | SODIUM BICARBONATE | Medical Purchasing Solutions, LLC | 09cf38c2-0b44-eca1-e063-6294a90a72d8 | 2023-11-10 | Warnings, Adverse reactions | 8MDF5V39QO |
| Levothyroxine sodium | LEVOTHYROXINE SODIUM | A-S Medication Solutions | 970b8456-5b9a-4839-9222-4ec1302266e2 | 2023-11-02 | Boxed warning, Warnings, Adverse reactions | 966222 9J765S329G |
| omeprazole sodium bicarbonate | OMEPRAZOLE SODIUM BICARBONATE | Cipla USA Inc. | 9cdde58a-ae8a-451f-92cf-cab178e4ba92 | 2023-11-01 | Warnings, Adverse reactions | 8MDF5V39QO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.